The relationship of retinopathy in persons without diabetes to the 15-year incidence of diabetes and hypertension: Beaver Dam Eye Study
- PMID: 17471330
- PMCID: PMC1809909
The relationship of retinopathy in persons without diabetes to the 15-year incidence of diabetes and hypertension: Beaver Dam Eye Study
Abstract
Purpose: To examine the relationship of retinopathy in persons without diabetes mellitus to the 15-year cumulative incidence of diabetes mellitus and hypertension.
Methods: A total of 3,402 persons 43 to 86 years of age without diabetes mellitus (1,879 without diabetes or hypertension) at the time of a baseline examination in 1988-1990 had follow-up examinations in 1993-1995, 1998-2000, and/or 2003-2005. Diabetes mellitus was defined by a combination of history, serum glucose levels, and glycosylated hemoglobin levels, and hypertension was defined as systolic blood pressure >/=140 mm Hg or diastolic blood pressure >/=90 mm Hg and/or use of antihypertensive medications. Retinopathy at baseline was determined by masked gradings of stereoscopic fundus photographs using standardized protocols.
Results: Retinopathy was present in 7.3% of the nondiabetic persons in the cohort and 5.4% of the nondiabetic, nonhypertensive cohort at baseline. The 15-year cumulative incidence of diabetes was 12.5% and of hypertension 54.1%. While controlling for age, persons with retinopathy were more likely to develop diabetes mellitus (odds ratio, 95% confidence interval, P value: 1.70, 1.17-2.48, P = .005) and hypertension (1.62, 1.18-2.23, P = .003) than persons without retinopathy. While controlling for other risk factors (eg, blood pressure, glucose level, cardiovascular disease history), the associations of retinopathy with incident diabetes mellitus (1.35, 0.90-2.03, P = .15) and hypertension (1.48, 1.05-2.07, P = .02) became attenuated but remained statistically significant for hypertension. In stratified analyses, retinopathy was associated with incident diabetes in persons younger than 65 years (1.80, 1.12-2.89, P = .02)
Conclusions: While controlling for other risk factors, retinopathy in nondiabetic individuals is associated with the incidence of hypertension and, in younger persons, with the incidence of diabetes mellitus.
Figures


Similar articles
-
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes.Ophthalmology. 2008 Nov;115(11):1859-68. doi: 10.1016/j.ophtha.2008.08.023. Ophthalmology. 2008. PMID: 19068374 Free PMC article.
-
15-year cumulative incidence and associated risk factors for retinopathy in nondiabetic persons.Arch Ophthalmol. 2010 Dec;128(12):1568-75. doi: 10.1001/archophthalmol.2010.298. Arch Ophthalmol. 2010. PMID: 21149781 Free PMC article.
-
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes.Ophthalmology. 1998 Oct;105(10):1801-15. doi: 10.1016/S0161-6420(98)91020-X. Ophthalmology. 1998. PMID: 9787347
-
The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes.Ophthalmology. 2009 Mar;116(3):497-503. doi: 10.1016/j.ophtha.2008.10.016. Epub 2009 Jan 22. Ophthalmology. 2009. PMID: 19167079 Free PMC article.
-
Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy.Arch Intern Med. 1994 Oct 10;154(19):2169-78. Arch Intern Med. 1994. PMID: 7944837
Cited by
-
In-silico, in-vitro and in-vivo Biological Activities of Flavonoids for the Management of Type 2 Diabetes.Curr Drug Discov Technol. 2024;21(5):e120124225551. doi: 10.2174/0115701638290819231228081120. Curr Drug Discov Technol. 2024. PMID: 38243931 Review.
-
Retinal vascular changes and diabetic retinopathy.Curr Diab Rep. 2009 Aug;9(4):277-83. doi: 10.1007/s11892-009-0043-4. Curr Diab Rep. 2009. PMID: 19640340 Review.
-
Relationship between retinal vessel diameters and retinopathy in the Inter99 Eye Study.J Clin Transl Endocrinol. 2017 Mar 21;8:22-28. doi: 10.1016/j.jcte.2017.03.002. eCollection 2017 Jun. J Clin Transl Endocrinol. 2017. PMID: 29067255 Free PMC article.
-
The Protective Role of Microglial PPARα in Diabetic Retinal Neurodegeneration and Neurovascular Dysfunction.Cells. 2022 Dec 1;11(23):3869. doi: 10.3390/cells11233869. Cells. 2022. PMID: 36497130 Free PMC article.
-
The Possible Role of Flavonoids in the Prevention of Diabetic Complications.Nutrients. 2016 May 20;8(5):310. doi: 10.3390/nu8050310. Nutrients. 2016. PMID: 27213445 Free PMC article. Review.
References
-
- Leibowitz HM, Krueger DE, Maunder LR, et al. The Framingham Eye Study Monograph. Surv Ophthalmol. 1980;24(suppl):335–610. - PubMed
-
- Nagi DK, Pettitt DJ, Klein R, Knowler WC. Diabetic retinopathy assessed by fundus photography in Pima Indians with impaired glucose tolerance and NIDDM. Diabet Med. 1997;14:449–456. - PubMed
-
- Yu T, Mitchell P, Berry G, Li W, Wang JJ. Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol. 1998;116:83–89. - PubMed
-
- Hubbard MAT, Brothers BS, King MS, et al. ARIC Study Group. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the atherosclerosis risk in communities study. Ophthalmolology. 1999;106:2269–2280. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical